Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (myeloid progenitor cells) in the bone marrow and other sites.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 1 PHASE2, 1 EARLY_PHASE1. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for chronic monocytic leukemia. Research spans Other (33%), Case Report / Case Series (33%), and Epidemiology / Natural History (33%).
Shuchismita (2025). [PMID: 40224679](https://pubmed.ncbi.nlm.nih.gov/40224679/). *Indian J Hematol Blood Transfus*. [Other]
Romero-Morelos P (2024). [PMID: 38792914](https://pubmed.ncbi.nlm.nih.gov/38792914/). *Medicina (Kaunas, Lithuania)*. [Epidemiology / Natural History]
Wang X (2024). [PMID: 39536687](https://pubmed.ncbi.nlm.nih.gov/39536687/). *Leukemia research*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:49 AM UTC
Common questions about chronic monocytic leukemia